HXL Falls 4% Into Q2 Print as Short Sellers Retreat
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Hexcel Corporation reports Q2 results on July 30 with the stock already under pressure — down 4% on the session to $105.61 — even as the broader short-selling community has been quietly stepping back from the name.
The short interest story has shifted meaningfully in recent weeks. Bears have been covering, not piling in: short interest dropped nearly 10% over the past week to 4.6% of the free float, and is down 17% from a month ago. Borrow availability remains extremely loose at 508%, meaning roughly five shares are available to lend for every one already borrowed — no squeeze pressure, no crowding. Cost to borrow is a negligible 0.57%. The ORTEX short score has also eased, falling from 48.7 a week ago to 45.4, reinforcing the picture of retreating rather than escalating bearish conviction. Options traders are equally relaxed: the put/call ratio is 0.28, barely a standard deviation above its 20-day average, and nowhere near levels that would signal defensive hedging into the print.
The bull and bear cases heading into today's release are sharply drawn. Bulls point to a projected roughly 50% jump in working business revenues over 2026–2028, a free cash flow run-rate of around $96.5 million — up 32% year-on-year and well above consensus — and the Defence, Space and Other segment growing 13% year-on-year to $182 million. The stock is up nearly 50% year-to-date, driven by those tailwinds. Bears counter with compressed margins — gross margins down to 21.9%, adjusted operating margins slipping to 9.8% — and guidance that was revised lower to reflect tariff headwinds and inventory destocking. Full-year revenue growth is expected at only around 8% at the midpoint. The analyst community reflects that tension: recent target raises from TD Cowen (to $100) and Jefferies (to $105) both kept Hold ratings, and the consensus mean target of $99.79 now sits below the current price of $105.61, suggesting the Street collectively sees the stock as running ahead of fundamentals. The valuation is not cheap — trailing PE near 39x and EV/EBITDA above 20x.
One data point that has not changed since yesterday's note is the CEO's insider activity. Nick Stanage sold over $11.6 million in stock across two transactions on July 14 and July 23, with no open-market purchases to offset. That pattern remains the most discussed signal around the stock heading into the print. Peers offer mixed context: HWM and GE both gained on the week, while ATI and CRS fell roughly 5% — suggesting some sector-level softness that HXL has not been immune to, particularly on today's session.
The Q2 print is therefore a test of whether the underlying revenue and margin trajectory can justify a valuation that has moved well past the consensus target, against a backdrop of an executive who has been a significant net seller at these levels.
Stocks in this article
See the live data behind this article on ORTEX.
Open HXL on ORTEX →How this article was generated
- Generated
- 30 Jul 2026, 04:11
- Data as of
- 30 Jul 2026, 03:53
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesPrevious Mi Articles
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.